Insiders Updates
A Guide To The Risks Of Investing In Esperion Therapeutics Inc (ESPR)
Esperion Therapeutics Inc’s recently made public that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $106.0 on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.